# A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia

> **NCT02968472** · PHASE1 · UNKNOWN · sponsor: **The First People's Hospital of Yunnan** · enrollment: 30 (estimated)

## Conditions studied

- B Acute Lymphoblastic Leukemia

## Interventions

- **GENETIC:** prophylactic 4SCAR19 cells

## Key facts

- **NCT ID:** NCT02968472
- **Lead sponsor:** The First People's Hospital of Yunnan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02968472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02968472, "A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02968472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*